Navigation Links
MicroMass Named Agency of Record for North Carolina Advanced Medical Technologies Center of Innovation
Date:3/23/2010

CARY, N.C. and MORRISTOWN, N.J., March 23 /PRNewswire/ -- MicroMass Communications, Inc., a world leader in behavioral marketing, has been named agency of record by the North Carolina Advanced Medical Technologies Center of Innovation (NC AMTC). MicroMass will be supporting the launch of the new center and its mission of promoting the growth of North Carolina's advanced medical technologies industry.

The full-service assignment will include a broad range of activities, focusing initially on creating a new name, logo, positioning tagline and Web site for the nonprofit center, which is based in Research Triangle Park. Future activities will include the development of strategic plans for advertising, publications, trade shows, media relations, and multi-channel marketing initiatives. The account team will be led by Shelly Weitz, management supervisor.

The NC AMTC was created to accelerate the growth of North Carolina's growing medical technologies industry, which includes more than 400 medical device, diagnostics and imaging companies. Funded by a grant from the North Carolina Biotechnology Center, NC AMTC's initial services will include an entrepreneur-in-residence program and grant writing assistance, in addition to other programs and services designed to help existing North Carolina AMT companies develop and commercialize their technologies faster and more efficiently.

"MicroMass is one of the top life science marketing and communications groups in the country, and headquartered here in North Carolina," said Cindy Clark, president of NC AMTC. "After an extensive request-for-proposal process, we chose MicroMass because of the agency's unique blend of creative vision, expertise in behavioral science, and intrinsic understanding of our marketing goals. Our partnership with MicroMass gives us a competitive advantage as we emerge into the national and international arena to make North Carolina one of the top hubs for medical technologies."

About MicroMass Communications, Inc.

Founded in 1994, MicroMass offers unrivaled capabilities in the application of behavioral science to marketing challenges. The company's approach is founded on the belief that understanding the critical factors that influence individual behavior is the best way to create dialogue and build enduring relationships between customers and brands.  

Unlike traditional agencies that are structured by discipline, MicroMass brings together under one roof the expertise and services for building sophisticated, multi-channel programs that span the full marketing continuum.

Headquartered in Cary, N.C., with a second office in Morristown, N.J., MicroMass is one of the fastest growing agencies in its field. With experience across life sciences categories, the company has a roster of clients that includes some of the most respected names in the industry. For more information, visit www.micromass.com.

    
    
    CONTACT: Julie Laitin (212) 286-2424     Cynthia Amorese (908) 665-8072
             Email: jlaitin@julielaitin.com  Email: camorese@comcast.net

SOURCE MicroMass Communications, Inc.

Back to top

RELATED LINKS
http://www.micromass.com

'/>"/>

SOURCE MicroMass Communications, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Aspirin Named 8th World Wonder by Majority of Americans
2. American Board of Internal Medicine President Named to Alzheimers Study Group
3. New York Infection Prevention Expert Named Recipient of Carole DeMille Award
4. Pharmaxis Establishes Named Patient Program for Bronchitol
5. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
6. Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
7. Battelle Scientists Named on Patent for Making Oxygen From Light and Water
8. Ikaria(R) Named Private Company of the Year by New Jersey Technology Council
9. Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
10. Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
11. EMD Serono, Inc. Named as a Top Employer by Science Magazine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
Breaking Medicine News(10 mins):